Megan Robertson, Member of the Firm, moderates "From States to FDA: Understanding the New Wave of Medical Device Enforcement" at the Food and Drug Law Institute (FDLI) Enforcement, Litigation, and Compliance Conference, which runs from December 4 to 5.
Medical device manufacturers and distributors are navigating enforcement from both state regulators targeting licensing violations and from FDA, including inspections, warning letters, recalls, actions targeting devices without proper 510k submissions, and more. This panel will explore the dual regulatory landscape, highlighting key state and federal actions from the past year. Attendees will gain practical strategies to manage compliance risks across both jurisdictions in this complex environment.
For more information, visit FDLI.org.
